Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a site revision tag (Revision: v3.4.2) and removed older funding-status notices (Revision: v3.4.1). These changes affect only the site metadata and do not modify the study details or eligibility information.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about government funding and NIH operations was added. The site revision number was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a Show glossary option and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a page revision note 'Revision: v3.4.0'. Older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed and the revision updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now includes a dedicated Locations section listing Massachusetts as a site, replacing the previous Massachusetts Locations subsection. A revision note shows the page updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page. This appears to be a minor metadata update rather than substantive changes to study information.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.